July 3, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Keytruda | European Medicines Agency (EMA) Noxafil | European Medicines Agency (EMA) Koselugo | European Medicines Agency (EMA) Lunsumio | European Medicines Agency (EMA) Xofluza | European Medicines Agency (EMA) Suliqua | European Medicines Agency (EMA) Aquipta | European Medicines Agency (EMA) NeoRecormon | European Medicines Agency (EMA) Kesimpta | European Medicines Agency (EMA) Lorviqua | European Medicines Agency (EMA)
